Ziphius Vaccines

Foundation date

2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class of vaccines, the messenger RNA or mRNA-based vaccines. More specifically, Ziphius focusses on self-amplifying mRNA-based vaccine. 

Upcoming events

Latest news

  • Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain

    15 hours ago

  • The new Walloon company Cellaïon makes its first closing

    15 hours ago

  • 7 (re)new(ed) strategic partnerships push flanders.bio forward into 2022

    10 hours ago

Jobs by Ziphius Vaccines